Literature DB >> 24137013

Renalase in hypertension and kidney disease.

Gary V Desir1, Aldo J Peixoto.   

Abstract

Renalase, a recently discovered flavoprotein, which is strongly expressed in the kidney and heart, effectively metabolizes catecholamines. It was discovered during the search to identify proteins secreted by the kidney that could help explain the high incidence of cardiovascular disease in patients with chronic kidney disease. Recent advances have led to more detailed knowledge of its biology, structure, enzymatic activity, mechanisms of action, associations with human disease states and potential therapeutic value. In this study, we review these advances with a focus on hypertension and kidney disease.

Entities:  

Keywords:  acute kidney injury; cardiovascular disease; hypertension; renalase; sympathetic nervous system

Mesh:

Substances:

Year:  2013        PMID: 24137013     DOI: 10.1093/ndt/gft083

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  33 in total

1.  Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.

Authors:  Carl D Langefeld; Mary E Comeau; Maggie C Y Ng; Meijian Guan; Latchezar Dimitrov; Poorva Mudgal; Mitzie H Spainhour; Bruce A Julian; Jeffrey C Edberg; Jennifer A Croker; Jasmin Divers; Pamela J Hicks; Donald W Bowden; Gary C Chan; Lijun Ma; Nicholette D Palmer; Robert P Kimberly; Barry I Freedman
Journal:  Kidney Int       Date:  2018-06-07       Impact factor: 10.612

2.  The role of urinary renalase on early-stage renal damage in Chinese adults with primary hypertension.

Authors:  Na-Na You; Wei-Hong Jiang; Ming-Yuan Lin; Xiao-Gang Li; Yu-Yan Wu; Jia-Ying Li; Xiao-Yu Zhou; Ze-Wen Ding; Jun-Wen Wang; Xie-Xiong Zhao; Hui-Ling Chen; Hui-Ting Tang
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-26

Review 3.  Cardiovascular Autonomic Dysfunction in Chronic Kidney Disease: a Comprehensive Review.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 4.  Antihypertensive mechanisms of intra-renal dopamine.

Authors:  Ming-Zhi Zhang; Raymond C Harris
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-03       Impact factor: 2.894

5.  Renalase: Another puzzle piece between hypertension and simple renal cysts?

Authors:  Omer Celal Elcioglu; Baris Afsar; Mumtaz Takir; Aybala Erek Toprak; Ali Bakan; Sibel Bakan; Osman Kostek; Alihan Oral; Hayriye Erman; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2015-05-19       Impact factor: 2.370

Review 6.  Renalase and Biomarkers of Contrast-Induced Acute Kidney Injury.

Authors:  Maciej T Wybraniec; Katarzyna Mizia-Stec
Journal:  Cardiorenal Med       Date:  2015-09-19       Impact factor: 2.041

7.  Polymorphism of the renalase gene in gestational diabetes mellitus.

Authors:  Syeda Sadia Fatima; Zehra Jamil; Faiza Alam; Hajira Zafar Malik; Sarosh Irfan Madhani; Muhammad Saad Ahmad; Tayyab Shabbir; Muhammed Noman Rehmani; Amna Rabbani
Journal:  Endocrine       Date:  2016-08-09       Impact factor: 3.633

8.  Down-regulation of miRNA 145 and up-regulation of miRNA 4516 may be associated with primary hypertension.

Authors:  Gülsüm Özkan; Şükrü Ulusoy; Elif Geyik; Yunus Erdem
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-26       Impact factor: 3.738

9.  Elevated renalase levels in patients with acute coronary microvascular dysfunction - A possible biomarker for ischemia.

Authors:  Basmah Safdar; Xiaojia Guo; Caitlin Johnson; Gail D'Onofrio; James Dziura; Albert J Sinusas; Jeffrey Testani; Veena Rao; Gary Desir
Journal:  Int J Cardiol       Date:  2019-01-02       Impact factor: 4.164

10.  The Effect of Bilateral Nephrectomy on Renalase and Catecholamines in Hemodialysis Patients.

Authors:  Magda Wiśniewska; Natalia Serwin; Violetta Dziedziejko; Małgorzata Marchelek-Myśliwiec; Barbara Dołęgowska; Leszek Domański; Kazimierz Ciechanowski; Krzysztof Safranow; Tomasz Gołębiowski; Andrzej Pawlik
Journal:  Int J Environ Res Public Health       Date:  2021-06-10       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.